| Position | Action |
|---|---|
| Technical deterioration (MACD histogram +2.10 to +0.02, 50 SMA rolling over from $154.73) | Trim 10-15% of XOM position at $153-156 zone (lower end of trim range) |
| Current position maintained after trim | Hold 85-90% of current XOM exposure (80-85% of neutral benchmark weight) |
| Confirmed close below 50 SMA at $146.28 on expanding volume | Execute second 5% tranche of trim |
| MACD histogram turning positive, RSI curling up, higher low forming at $144-148 zone | Reload first tranche |
| Operating margin stabilizes above 8% for two consecutive quarters AND net debt plateaus at $138-140 | Reload second tranche |
| Price above $155 without MACD bullish crossover and sustained Brent >$85 | Avoid adding |
ExxonMobil is positioned to outperform due to cyclical trough recovery in Q2 2026, record refining margins, Guyana production ramp, and a technically-defined entry point offering asymmetric risk-reward with a 9% downside floor versus 9% upside to fair value.
| Indicator | Value | Signal |
|---|---|---|
| Close | 151.63 | bearish |
| Open | 155.04 | — |
| High | 155.04 | — |
| Low | 151.15 | — |
| Volume | 12,188,198 | bearish |
| 10 EMA | 153.51 | bearish |
| 50 SMA | 146.28 | neutral |
| 200 SMA | 138.70 | bullish |
| RSI (14) | 53.63 | neutral |
| MACD | +2.94 | neutral |
| MACD Histogram | +0.02 | bearish |
| Bollinger Middle (20 SMA) | 150.49 | neutral |
| Bollinger Upper Band | 162.67 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Trim 10-15% on technical breakdown; retain 80-85% neutral weight due to dividend floor and defensive beta
Trim XOM 10-15% at $153-156 (lower end of range) to capture asymmetric technical deterioration (MACD histogram +2.10 → +0.02, 50 SMA rolling over from $154.73, 10 EMA broken) and forward-EPS risk ($10.56 consensus vs. $7.50-8.50 base case) while maintaining 80-85% of neutral benchmark weight. The dividend floor (1.37x FCF coverage, 2.66% yield, 12+ years of increases), 0.17 beta defensive characteristics, and structural floor at 200 SMA justify preserving more position than aggressive trim scenarios. Eliminate the $137 stop (self-fulfilling prophecy at structural support); drop to $130 or remove on trimmed portion. Reload in tranches: first at $144-148 with MACD/RSI confirmation, second at $138-140 only on operating margin stabilization. Prior pattern alpha of 100-200 bps and marginal realized edge (-1.3%, -2.5%, -1.7%, -1.7% across four recent decisions) counsel against oversizing the trim.
When: Current opportunity at $153-156 zone
Then: Trim 10-15%
· concedes: 50 EMA break, MACD histogram flattening, and 50 SMA rollover are real near-term headwinds; Gross margin compression in Q1 was genuine; Trump headlines create volatility; Q2 print missed headline estimates; 5% stop loss at $138 required
XOM is a structurally deteriorating business masquerading as a cyclical buy—the company is borrowing to fund shareholder returns, consensus EPS is a peak-case fantasy, and geopolitical/technical tailwinds are already unwinding, making the $151.63 entry point an asymmetric risk to the downside.
· concedes: The 200 SMA at $138.70 is real structural support—a test of that level is plausible; The $37B annual capital return is genuinely shareholder-friendly, even if funded by debt today; The integrated model provides real ballast in volatile markets; Q2 2026 was a strong print, even if it missed expectations
→ vs conservative: 2.66% dividend yield and '12-plus years of consecutive increases' is a psychological floor, not a fundamental one; ConocoPhillips and Pioneer cut dividends before XOM; XOM is funding dividends with debt issuance
→ vs conservative: Beta of 0.17 means underperformance on upside too, not protection against forward drawdown; XOM can still drop 30% in an energy rout
→ vs neutral: 'Wait for confirmation, hold' is the most expensive sentence in trading; waiting costs 20-30% downside while upside is only 9% to intrinsic value — roughly 3-to-1 against the holder
→ vs neutral: The 9% undervaluation DCF is anchored on Brent above $85 and current refining margins — both inputs most likely to deteriorate with Iran deal optimism
→ vs neutral: The 200 SMA at $138 being intact is misleading; by the time it breaks you're already at $138-$145; trim when momentum rolls over, not when the 200 SMA gets hit
→ vs neutral: Sentiment being 'mildly bullish at 6.2/10 with low confidence' hides that retail is completely absent — no cushion when institutional flows reverse
| neutral |
| Bollinger Lower Band | 138.31 | bullish |
| ATR (14) | 3.86 | — |
| VWMA | 153.58 | bearish |
Support: 150.49 · 146.28 · 138.31 | Resistance: 153.51 · 162.67
XOM exhibits a classic bullish-but-pulling-back configuration: the long-term uptrend (200 SMA at 138.70, rising) and price hierarchy (151.63 > 50 SMA > 200 SMA) remain structurally sound, but short-term momentum has flipped bearish with the MACD histogram near zero (+0.02, down from +2.10 peak on 2026-07-24), price closing below the 10 EMA (153.51), and the 50 SMA declining from its 154.73 peak on 2026-05-22. RSI has cooled from overbought (72.17) to neutral (53.63), creating space for renewed upside. Key support lies at 138.31-138.70 (lower Bollinger band + 200 SMA confluence), with resistance at 153.51 (10 EMA) and 162.67 (upper band). The recommended action is HOLD, awaiting a pullback to the 146-150 zone before adding exposure.
Market Cap
$628.5B
Beta
0.173
52-Week High
$176.41
52-Week Low
$105.53
Current Price
~$151.65
Dividend Yield
2.66%
EPS (TTM)
$5.94
Forward EPS
$10.56
P/E (TTM)
25.5×
Forward P/E
14.4×
PEG Ratio
1.32
Price/Book
2.40×
Book Value/Share
$63.08
Revenue 2025
$323,905M
Revenue 2024
$339,247M
Revenue 2023
$334,697M
Revenue 2022
$398,675M
Gross Profit 2025
$71,240M
Operating Income 2025
$33,938M
EBITDA 2025
$67,864M
Net Income 2025
$28,844M
Diluted EPS 2025
$6.70
Diluted EPS 2024
$7.84
Diluted EPS 2023
$8.89
Diluted EPS 2022
$13.26
Q1 2026 Revenue
$83,161M
Q1 2026 Gross Profit
$13,893M
Q1 2026 Net Income
$4,183M
Q1 2026 Diluted EPS
$1.00
Q1 2026 Gross Margin
16.7%
Q1 2026 Effective Tax Rate
35.8%
Profit Margin (TTM)
9.07%
Operating Margin (TTM)
15.86%
Return on Equity (ROE)
12.58%
Return on Assets (ROA)
5.52%
Cash 2025
$10,681M
Cash Q1 2026
$8,435M
Total Assets 2025
$448,980M
Total Assets Q1 2026
$464,410M
Total Debt Q1 2026
$47,661M
Net Debt 2025
$26,543M
Net Debt Q1 2026
$39,226M
Stockholders' Equity Q1 2026
$254,381M
Working Capital Q1 2026
$3,409M
Debt/Equity Q1 2026
~18.7%
Operating CF 2025
$51,970M
Operating CF Q1 2026
$8,705M
CapEx 2025
$28,358M
CapEx Q1 2026
$6,470M
FCF 2025
$23,612M
FCF Q1 2026
$2,235M
Dividends Paid 2025
$17,231M
Share Buybacks 2025
$20,273M
Total Shareholder Return 2025
~$37,500M
Diluted Share Count Q1 2026
4.202B
FCF Yield (2025)
~3.8%
Total Shareholder Yield
~5.9%
Strengths
Concerns
ExxonMobil (XOM) presents a mixed near-term picture: Q1 2026 results show meaningful deterioration with EPS falling to $1.00, net income down 45% from peak, and gross margins compressing to 16.7%, while net debt nearly doubled year-over-year to $39.2B and FCF fell to a cycle low of $2.2B. However, the company maintains structural strengths including an ultra-defensive beta of 0.17, massive $361B annual revenue base, investment-grade balance sheet with conservative 18.7% debt/equity, and industry-leading capital return commitments of ~$37.5B annually. The stock is fairly valued to modestly expensive on near-term fundamentals at 25.5× TTM P/E, though the 14.4× forward P/E offers reasonable entry if commodity prices normalize. Near-term traders should wait for Q2/Q3 2026 earnings confirmation of margin stabilization before adding positions.